还原型谷胱甘肽联合苦参碱治疗慢性乙肝的临床观察
:覃后继,覃雪英,何延专
【摘要】目的观察还原型谷胱甘肽联合苦参碱对慢性乙型肝炎的疗效。方法将163 例慢性乙型肝炎患者随机分为两组, 治疗组83 例给予苦参碱及还原型谷胱甘肽治疗;对照组80例单纯给予还原型谷胱甘肽。两组疗程均为8周。观察患者血清丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、碱性磷酸酶(ALP)、r谷氨酰转肽氨酶(rGT)、总胆红素(TBil)、透明质酸(HA)、层黏蛋白(LN)、IV 型胶原(IVC)、Ⅲ型胶原(PCⅢ) 及门静脉内径(D)值变化情况。结果治疗组治疗后的ALT、AST、ALP、rGT、TBil、HA、LN、IVC、PCⅢ均降低,D 值变小,与治疗前比较有显著性差异( P<)。与对照组治疗后比较,改善更明显,有非常显著性差异( P<)。% %,差异有非常显著性( P<)。结论还原型谷胱甘肽联用苦参碱治疗慢性乙型肝炎,在降酶、退黄、抗肝纤维化、缩小D 值及改善临床症状方面有协同作用。
【关键词】还原型谷胱甘肽;苦参碱;慢性乙型肝炎
【Abstract】 Objective To observe the curative effect of reduced glutathione bined atrine in chronic hepatitis 163 cases of chronic hepatitis B patients ly divided into tent group atrine. 80 cases in control group ply given reduced glutathione. T alanine aminotransferase (ALT),aspartate aminotransferase (AST),alkaline phosphatase (ALP),rglutamyl transpeptidase in ammonia(rGT), total bilirubin (TBil ), hyaluronic acid (HA),laminin (LN), type IV collagen (IVC), collagen type Ⅲ(PC Ⅲ) and the portal vein diameter (D) level of ALT,AST,ALP,rGT, TBil,HA,LN,IVC,PC Ⅲ in treatment group ent, and the D value ent, there ent group and the control group ent of chronic hepatitis B bined reduced glutathione atrine in reducing serum transaminase and serum bilirubin level, antiliver fibrosis,and narroproving the clinical symptoms have collaborative effect.
【Key atrine;chr
还原型谷胱甘肽联合苦参碱治疗慢性乙肝的临床观察 来自淘豆网m.daumloan.com转载请标明出处.